Clinical experience with AcrySof ReSTOR lens in cataract patients
October 1st 2005Approved by the FDA in March 2005 for use in cataract patients with or without presbyopia, Alcon's AcrySof ReSTOR lens is the first apodized diffractive intraocular lens (IOL) to be made available. The approval was granted based on clinical trials which found that patients experienced the highest level of freedom from glasses ever achieved in IOL clinical trials.
XXIII ESCRS Congress: Coaxial microphaco & sealed capsule irrigation
October 1st 2005Coaxial microphacoemulsification performed through a 2.2 mm incision is a new technique available to cataract surgeons skilled in phacoemulsification. The technique affords patients the combined benefits of ultra-small incision surgery and conventional foldable IOLs, announced Robert H. Osher, MD, professor of ophthalmology, University of Cincinnati College of Medicine, and medical director emeritus, Cincinnati Eye Institute, Cincinnati, Ohio, USA.
Night-driving simulator may influence future IOL safety tests
May 9th 7In a night-driving simulation, fog and glare separately reduced sign recognition distances but when combined paradoxically increased performance relative to either factor alone. However, fog and glare reduced object recognition both separately and when paired, said Bruce A. Drum, PhD, Division of Ophthalmic and ENT Devices, FDA, Rockville, MD.